iiinova — where your digital self keeps evolving

UK-CAB

@ukcab.bsky.social

HIV treatment advocates network: Supporting advocates in the UK | Providing expert training on treatment | Ensuring PLWHIV represented at all levels of our care

Posts Replies Media

UK-CAB @ukcab.bsky.social · 27/04/2026

If you are attending to #BHIVABASHH26 in Liverpool, come and visit us in the exhibition hall! @positivelyuk.bsky.social @angelinanamiba.bsky.social @haruntulunay.bsky.social @nat.org.uk @bhiva.bsky.social @bashhuk.bsky.social

0106

UK-CAB @ukcab.bsky.social · 19/03/2026

Join UK-CAB to shape the future of HIV care. ukcab.net/about/join/

002

UK-CAB @ukcab.bsky.social · 06/12/2025

The HIV Action Plan has promise — but real progress needs action and accountability. Prisons, women, trans people + marginalised groups must not be left behind. You can read our public statement regarding to new HIV Action Plan below.

022

UK-CAB @ukcab.bsky.social · 06/08/2025

We encourage all people living with HIV in Europe to join this short study run by @shareeastlondon.bsky.social & @profchloeorkin.bsky.social to share their experiences with new HIV treatments & conversations with the clinical teams about treatment choices. Visit the page & complete the survey below

035

UK-CAB @ukcab.bsky.social · 19/06/2025

🚨 Gilead’s lenacapavir could be a game-changer for #HIV — but at $28K/year, it’s priced out of reach for most. Generics could cost <$50. We’re calling on Gilead to make it affordable for all, not just the privileged few. Please find UK-CAB public response below.

022

UK-CAB @ukcab.bsky.social · 23/05/2025

🚨 The Lenacapavir Early Access Programme has closed to new patients. This life-saving #HIV treatment is now out of reach for those who need it most. We urge NHS England & Gilead to act now. Access to Lenacapavir must be restored. Urgently. Community organisations: speak up. Silence costs lives.

114

UK-CAB @ukcab.bsky.social · 01/05/2025

UK-CAB deeply concerned about GSK/ViiV diversity policy implications globally, despite UK/EU assurances. Erosion anywhere sets a dangerous precedent. Our community is alarmed by US policy shifts & PEPFAR threats. Please read our statement below. #HIV #Diversity #GlobalHealth #UKCAB

Public Statement from UK-CAB on GSK/ViiV Diversity Policy Concerns

063

UK-CAB @ukcab.bsky.social · 30/04/2025

New @abpi.bsky.social guidance risks excluding #HIV advocates from conferences — suggesting we’re too “impressionable” to hear about treatments. We reject this. People with HIV are informed, critical partners in progress. You can read our response below. #NothingAboutUsWithoutUs #HIVAdvocacy

UK-CAb Response to the new ABPI Conference Guidance

142